Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 33 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 9867830

    Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  2. US 9868943

    Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  3. US 9868954

    Reduction of TGFβ signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  4. US 9862679

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  5. US 9856453

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  6. US 9855298

    Methods of conditioning patients for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  7. US 9855330

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  8. US 9856313

    Epitope of RSV fusion protein and antibody recognizing the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  9. US 9850468

    Infectious hepatitis E virus genotype 3 recombinants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

  10. US 9845350

    Monoclonal antibodies that react with the capsule of bacillus anthracis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  11. US 9833519

    Methods for the diagnosis and treatment of sjögren's syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  12. US 9827223

    Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted

  13. US 9820965

    Biologically active macrolides, compositions, and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  14. US 9821029

    Methods of reducing salmonella in poultry

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  15. US 9822162

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  16. US 9815887

    Monoclonal antibodies that neutralize a norovirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  17. US 9814771

    Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  18. US 9808520

    Rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  19. US 9808458

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  20. US 9803022

    Mesothelin domain-specific monoclonal antibodies and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  21. US 9802904

    Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  22. US 9804163

    Biomarkers for prostate cancer and methods for their detection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  23. US 9795662

    Vaccine comprising AMA1 and RON2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  24. US 9795665

    Attenuated live vaccine for Crimean-Congo hemorrhagic fever virus and Erve virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.